World's Best Scientists 2026 revealed!
Dieter Kabelitz

Dieter Kabelitz

D-Index & Metrics

Immunology

D-Index
80
Citations
22444
World Ranking
1635
National Ranking
112

Dieter Kabelitz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dieter Kabelitz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 432 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dieter Kabelitz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dieter Kabelitz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dieter Kabelitz is affiliated with Kiel University in Germany and specializes in immunology and microbiology, with a significant focus on medicine. Their research interests span multiple subfields including immunology, oncology, molecular biology, epidemiology, and pathology and forensic medicine. The main topics of their work cover immune cell function and interaction, T-cell and B-cell immunology, CAR-T cell therapy research, immunotherapy and immune responses, cancer immunotherapy and biomarkers, as well as vitamin C and vitamin D related antioxidant research.

The scientist has published extensively in several academic venues, with frequent publications appearing in the Scandinavian Journal of Immunology, Cellular and Molecular Immunology, Frontiers in Immunology, Cells, and Signal Transduction and Targeted Therapy. These venues highlight a consistent contribution to the field of immunological research.

Notable recent papers by Dieter Kabelitz include:

  • Cancer immunotherapy with γδ T cells: many paths ahead of us, 2020, Cellular and Molecular Immunology
  • The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System, 2020, Frontiers in Immunology
  • γδ T cells: origin and fate, subsets, diseases and immunotherapy, 2023, Signal Transduction and Targeted Therapy
  • Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer, 2020, Cellular and Molecular Immunology
  • Tumor resistance mechanisms and their consequences on γδ T cell activation, 2020, Immunological Reviews

Dieter Kabelitz collaborates regularly with a group of frequent coauthors, including Christian Peters, Kurosh Kalantar, Jaydeep Bhat, Daniela Wesch, and Ruben Serrano. This network reflects ongoing partnerships within the immunology research community.

Their scientific output focuses heavily on understanding immune cell types such as γδ T cells and their roles in cancer immunotherapy, alongside broader investigations of immune cell function and interaction. Studies on CAR-T cell therapy and immune responses form an important part of their research portfolio.

Best Publications

  • Human T-cell receptor variable gene segment families.

    Bernhard Arden;Stephen P. Clark;Dieter Kabelitz;Tak W. Mak

  • Compartmentalization of TNF Receptor 1 Signaling: Internalized TNF Receptosomes as Death Signaling Vesicles

    Wulf Schneider-Brachert;Vladimir Tchikov;Jens Neumeyer;Marten Jakob

  • The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

    Gholamreza Daryabor;Mohamad Reza Atashzar;Dieter Kabelitz;Seppo Meri

  • Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells

    S Wesselborg;O Janssen;D Kabelitz

  • Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.

    Sebastian Hinz;Laia Pagerols-Raluy;Hans-Heinrich Oberg;Ole Ammerpohl

  • Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

    Eva Ellinghaus;David Ellinghaus;Philip E Stuart;Rajan P Nair

  • Activation of Vγ9Vδ2 T Cells by NKG2D

    Bladimiro Rincon-Orozco;Volker Kunzmann;Philine Wrobel;Dieter Kabelitz

  • Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis.

    Lars Klareskog;Urban Forsum;Annika Scheynius;Dieter Kabelitz

  • gammadelta T cells link innate and adaptive immune responses.

    Wolfgang Holtmeier;Dieter Kabelitz

  • Perspectives of γδ T Cells in Tumor Immunology

    Dieter Kabelitz;Daniela Wesch;Wei He

  • Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis

    Rajan P. Nair;Andreas Ruether;Philip E. Stuart;Stefan Jenisch

  • Expression and function of Toll-like receptors in T lymphocytes

    Unknown

  • Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: Involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition

    P. Wrobel;H. Shojaei;B. Schittek;F. Gieseler

  • Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.

    Ole Helm;Janka Held-Feindt;Evelin Grage-Griebenow;Norbert Reiling

  • Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients

    James A. Hutchinson;James A. Hutchinson;Paloma Riquelme;Paloma Riquelme;Birgit Sawitzki;Birgit Sawitzki;Stefan Tomiuk;Stefan Tomiuk

  • Cancer immunotherapy with γδ T cells: many paths ahead of us

    Dieter Kabelitz;Ruben Serrano;Léonce Kouakanou;Christian Peters

  • The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness.

    Daisy Melandri;Daisy Melandri;Iva Zlatareva;Iva Zlatareva;Raphaël A.G. Chaleil;Robin J. Dart;Robin J. Dart

  • Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.

    Guranda Chitadze;Marcus Lettau;Jaydeep Bhat;Daniela Wesch

  • Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo

    Dieter Kabelitz;Daniela Wesch;Elke Pitters;Margot Zöller

  • Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.

    Yan Xu;Zheng Xiang;Mohammed Alnaggar;Mohammed Alnaggar;Léonce Kouakanou

  • Patterns of Chemokine Receptor Expression on Peripheral Blood γδ T Lymphocytes: Strong Expression of CCR5 Is a Selective Feature of Vδ2/Vγ9 γδ T Cells

    Andrea Glatzel;Daniela Wesch;Florian Schiemann;Ernst Brandt

  • Direct Costimulatory Effect of TLR3 Ligand Poly(I:C) on Human γδ T Lymphocytes

    Daniela Wesch;Susann Beetz;Hans-Heinrich Oberg;Matthias Marget

  • T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells.

    O Janssen;S Wesselborg;B Heckl-Ostreicher;K Pechhold

  • Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines.

    Dieter Kabelitz;Ruslan Medzhitov

Frequent Co-Authors

Daniela Wesch
Daniela Wesch Kiel University
Ottmar Janssen
Ottmar Janssen Kiel University
Matthias Peipp
Matthias Peipp Kiel University
Christoph Röcken
Christoph Röcken Kiel University
Ole Ammerpohl
Ole Ammerpohl University of Ulm
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
Adrian Hayday
Adrian Hayday King's College London
Reiner Siebert
Reiner Siebert University of Ulm
Andre Franke
Andre Franke Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing professionals often bridge their expertise with advanced practices by pursuing specialized certifications. Programs such as the top pmhnp programs offer excellent clinical placement rates, providing vital hands-on experience in psychiatric nursing.

Affordability is a major consideration for many students, and the cheapest online pmhnp certificate programs enable candidates to enter this specialized field without a significant financial burden. These certificates are valuable for those looking to quickly advance their qualifications.

Understanding salary potential is crucial when selecting a career path. According to sources detailing dnp salary data, nurse practitioners with a Doctor of Nursing Practice degree can expect competitive compensation that varies by state, reflecting demand and specialization.

Transitioning within nursing specialties is also a popular route. For example, experienced Family Nurse Practitioners can enhance their careers by enrolling in an fnp to acnp bridge program online, gaining acute care expertise while continuing full-time work.

Best Scientists Citing Dieter Kabelitz

Trending Scientists

Recently Published Articles